Vitamin D-binding protein in plasma microglia-derived extracellular vesicles as a potential biomarker for major depressive disorder

Genes and Diseases - Tập 11 - Trang 1009-1021 - 2024
Gaojia Zhang1, Ling Li1, Yan Kong2, Dandan Xu1, Yu Bao3, Zhiting Zhang4, Zhixiang Liao5, Jiao Jiao1, Dandan Fan1, Xiaojing Long5, Ji Dai4,6, Chunming Xie1, Zhiqiang Meng3,4,6, Zhijun Zhang1,7
1Department of Neurology, Affiliated Zhongda Hospital, Research Institution of Neuropsychiatry, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China
2Department of Biochemistry and Molecular Biology, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China
3Shenzhen Key Laboratory of Drug Addiction, Brain Cognition and Brain Disease Institute, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences (CAS), Shenzhen, Guangdong 518000, China
4CAS Key Laboratory of Brain Connectome and Manipulation, The Brain Cognition and Brain Disease Institute (BCBDI), Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China
5Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China
6Shenzhen-Hong Kong Institute of Brain Sciences-Shenzhen Fundamental Research Institutions, Shenzhen, Guangdong 518000, China
7Brain Cognition and Brain Disease Institute, Department of Mental Health and Public Health, Faculty of Life and Health Sciences, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, Guangdong 518055, China

Tài liệu tham khảo

Kitanaka, 2021, The social in psychiatries: depression in Myanmar, China, and Japan, Lancet, 398, 948, 10.1016/S0140-6736(21)00999-5 Santomauro, 2021, Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic, Lancet, 398, 1700, 10.1016/S0140-6736(21)02143-7 Huang, 2021, 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study, Lancet, 397, 220, 10.1016/S0140-6736(20)32656-8 Shi, 2020, Identifying plasma biomarkers with high specificity for major depressive disorder: a multi-level proteomics study, J Affect Disord, 277, 620, 10.1016/j.jad.2020.08.078 Kennis, 2020, Prospective biomarkers of major depressive disorder: a systematic review and meta-analysis, Mol Psychiatr, 25, 321, 10.1038/s41380-019-0585-z Gururajan, 2016, Molecular biomarkers of depression, Neurosci Biobehav Rev, 64, 101, 10.1016/j.neubiorev.2016.02.011 Menezes, 2019, Genetic biomarkers for differential diagnosis of major depressive disorder and bipolar disorder: a systematic and critical review, Behav Brain Res, 357–358, 29, 10.1016/j.bbr.2018.01.008 Hernandez-Baixauli, 2021, Alterations in metabolome and microbiome associated with an early stress stage in male Wistar rats: a multi-omics approach, Int J Mol Sci, 22, 10.3390/ijms222312931 Bu, 2021, Diagnostic biomarker Hsa_circ_0126218 and functioning prediction in peripheral blood monocular cells of female patients with major depressive disorder, Front Cell Dev Biol, 9, 10.3389/fcell.2021.651803 Martins-de-Souza, 2014, Proteomics, metabolomics, and protein interactomics in the characterization of the molecular features of major depressive disorder, Dialogues Clin Neurosci, 16, 63, 10.31887/DCNS.2014.16.1/dmartins McCarron, 2021, Depression, Ann Intern Med, 174, ITC65, 10.7326/AITC202105180 Enache, 2019, Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue, Brain Behav Immun, 81, 24, 10.1016/j.bbi.2019.06.015 Shi, 2019, New windows into the brain: central nervous system-derived extracellular vesicles in blood, Prog Neurobiol, 175, 96, 10.1016/j.pneurobio.2019.01.005 Kalluri, 2020, The biology, function, and biomedical applications of exosomes, Science, 367, 10.1126/science.aau6977 Escudé Martinez de Castilla, 2021, Extracellular vesicles as a drug delivery system: a systematic review of preclinical studies, Adv Drug Deliv Rev, 175, 10.1016/j.addr.2021.05.011 Duarte-Silva, 2022, Tiny in size, big in impact: extracellular vesicles as modulators of mood, anxiety and neurodevelopmental disorders, Neurosci Biobehav Rev, 135, 10.1016/j.neubiorev.2022.104582 Goetzl Edward, 2016, Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease, FASEB J, 30, 3853, 10.1096/fj.201600756R Shi, 2016, CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease, Alzheimers Dement, 12, 1125, 10.1016/j.jalz.2016.04.003 Kumar, 2021, Brain cell-derived exosomes in plasma serve as neurodegeneration biomarkers in male cynomolgus monkeys self-administrating oxycodone, EBioMedicine, 63, 10.1016/j.ebiom.2020.103192 Jia, 2019, Concordance between the assessment of Aβ42, T-tau, and P-T181-tau in peripheral blood neuronal-derived exosomes and cerebrospinal fluid, Alzheimers Dement, 15, 1071, 10.1016/j.jalz.2019.05.002 Saeedi, 2021, Neuron-derived extracellular vesicles enriched from plasma show altered size and miRNA cargo as a function of antidepressant drug response, Mol Psychiatr, 26, 7417, 10.1038/s41380-021-01255-2 Shi, 2014, Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson's disease, Acta Neuropathol, 128, 639, 10.1007/s00401-014-1314-y Yu, 2020, Reduced oligodendrocyte exosome secretion in multiple system atrophy involves SNARE dysfunction, Brain, 143, 1780, 10.1093/brain/awaa110 Fiandaca, 2015, Identification of preclinical Alzheimer's disease by a profile of pathogenic proteins in neurally derived blood exosomes: a case-control study, Alzheimers Dement, 11, 600, 10.1016/j.jalz.2014.06.008 Goetzl, 2018, High complement levels in astrocyte-derived exosomes of Alzheimer disease, Ann Neurol, 83, 544, 10.1002/ana.25172 Goetzl, 2015, Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease, Neurology, 85, 40, 10.1212/WNL.0000000000001702 Agliardi, 2019, SNAP-25 in serum is carried by exosomes of neuronal origin and is a potential biomarker of Alzheimer's disease, Mol Neurobiol, 56, 5792, 10.1007/s12035-019-1501-x Dutta, 2021, α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy, Acta Neuropathol, 142, 495, 10.1007/s00401-021-02324-0 Athauda, 2019, Utility of neuronal-derived exosomes to examine molecular mechanisms that affect motor function in patients with Parkinson disease: a secondary analysis of the exenatide-PD trial, JAMA Neurol, 76, 420, 10.1001/jamaneurol.2018.4304 Jiang, 2020, Serum neuronal exosomes predict and differentiate Parkinson's disease from atypical Parkinsonism, J Neurol Neurosurg Psychiatry, 91, 720, 10.1136/jnnp-2019-322588 Niu, 2020, A longitudinal study on α-synuclein in plasma neuronal exosomes as a biomarker for Parkinson's disease development and progression, Eur J Neurol, 27, 967, 10.1111/ene.14208 Zhao, 2019, Increased DJ-1 and α-synuclein in plasma neural-derived exosomes as potential markers for Parkinson's disease, Front Aging Neurosci, 10, 438, 10.3389/fnagi.2018.00438 Hamlett, 2017, Neuronal exosomes reveal Alzheimer's disease biomarkers in Down syndrome, Alzheimers Dement, 13, 541, 10.1016/j.jalz.2016.08.012 Goetzl, 2019, Altered levels of plasma neuron-derived exosomes and their cargo proteins characterize acute and chronic mild traumatic brain injury, Faseb J, 33, 5082, 10.1096/fj.201802319R Goetzl, 2020, Neuron-derived plasma exosome proteins after remote traumatic brain injury, J Neurotrauma, 37, 382, 10.1089/neu.2019.6711 Winston, 2019, Assessing neuronal and astrocyte derived exosomes from individuals with mild traumatic brain injury for markers of neurodegeneration and cytotoxic activity, Front Neurosci, 13, 1005, 10.3389/fnins.2019.01005 Nasca, 2021, Insulin receptor substrate in brain-enriched exosomes in subjects with major depression: on the path of creation of biosignatures of central insulin resistance, Mol Psychiatr, 26, 5140, 10.1038/s41380-020-0804-7 Goetzl, 2021, Abnormal levels of mitochondrial proteins in plasma neuronal extracellular vesicles in major depressive disorder, Mol Psychiatr, 26, 7355, 10.1038/s41380-021-01268-x Xie, 2023, Hyper-inflammation of astrocytes in patients of major depressive disorder: evidence from serum astrocyte-derived extracellular vesicles, Brain Behav Immun, 109, 51, 10.1016/j.bbi.2022.12.014 Qin, 2019, Chronic glucocorticoid exposure induces depression-like phenotype in rhesus macaque (Macaca mulatta), Front Neurosci, 13, 188, 10.3389/fnins.2019.00188 Felger, 2007, Effects of interferon-alpha on rhesus monkeys: a nonhuman primate model of cytokine-induced depression, Biol Psychiatr, 62, 1324, 10.1016/j.biopsych.2007.05.026 Harlow, 1971, Social recovery by isolation-reared monkeys, Proc Natl Acad Sci U S A, 68, 1534, 10.1073/pnas.68.7.1534 Shively, 2005, Social stress-associated depression in adult female cynomolgus monkeys (Macaca fascicularis), Biol Psychol, 69, 67, 10.1016/j.biopsycho.2004.11.006 Davenport, 2006, Analysis of endogenous cortisol concentrations in the hair of rhesus macaques, Gen Comp Endocrinol, 147, 255, 10.1016/j.ygcen.2006.01.005 Zhang, 2020, CircDYM ameliorates depressive-like behavior by targeting miR-9 to regulate microglial activation via HSP90 ubiquitination, Mol Psychiatr, 25, 1175, 10.1038/s41380-018-0285-0 Lu, 2020, Magnetic brain stimulation using iron oxide nanoparticle-mediated selective treatment of the left prelimbic cortex as a novel strategy to rapidly improve depressive-like symptoms in mice, Zool Res, 41, 381, 10.24272/j.issn.2095-8137.2020.076 Ruan, 2022, A new understanding of TMEM119 as a marker of microglia, Front Cell Neurosci, 16, 10.3389/fncel.2022.902372 Bennett, 2016, New tools for studying microglia in the mouse and human CNS, Proc Natl Acad Sci U S A, 113, E1738, 10.1073/pnas.1525528113 Satoh, 2016, TMEM119 marks a subset of microglia in the human brain, Neuropathology, 36, 39, 10.1111/neup.12235 Bohnert, 2020, TMEM119 as a specific marker of microglia reaction in traumatic brain injury in postmortem examination, Int J Leg Med, 134, 2167, 10.1007/s00414-020-02384-z Speeckaert, 2014, Vitamin D binding protein: a multifunctional protein of clinical importance, Adv Clin Chem, 63, 1, 10.1016/B978-0-12-800094-6.00001-7 Bouillon, 2020, Vitamin D binding protein: a historic overview, Front Endocrinol, 10, 910, 10.3389/fendo.2019.00910 McLeod, 1989, The vitamin D-binding protein, alpha-fetoprotein, albumin multigene family: detection of transcripts in multiple tissues, J Biol Chem, 264, 21760, 10.1016/S0021-9258(20)88249-0 Dziegielewska, 1986, Synthesis of plasma proteins in fetal, adult, and neoplastic human brain tissue, Dev Biol, 115, 93, 10.1016/0012-1606(86)90231-9 Carlyle, 2017, A multiregional proteomic survey of the postnatal human brain, Nat Neurosci, 20, 1787, 10.1038/s41593-017-0011-2 Geiger, 2013, Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse, Mol Cell Proteomics, 12, 1709, 10.1074/mcp.M112.024919 Huttlin, 2010, A tissue-specific atlas of mouse protein phosphorylation and expression, Cell, 143, 1174, 10.1016/j.cell.2010.12.001 Jirikowski, 2009, Distribution of vitamin D binding protein expressing neurons in the rat hypothalamus, Histochem Cell Biol, 131, 365, 10.1007/s00418-008-0540-6 Moon, 2013, Vitamin D-binding protein interacts with Aβ and suppresses Aβ-mediated pathology, Cell Death Differ, 20, 630, 10.1038/cdd.2012.161 Jeon, 2019, Vitamin D-binding protein-loaded PLGA nanoparticles suppress Alzheimer's disease-related pathology in 5XFAD mice, Nanomed Nanotechnol Biol Med, 17, 297, 10.1016/j.nano.2019.02.004 Kułakowska, 2018, Pathophysiological implications of actin-free Gc-globulin concentration changes in blood plasma and cerebrospinal fluid collected from patients with Alzheimer's disease and other neurological disorders, Adv Clin Exp Med, 27, 1075, 10.17219/acem/70441 Zhang, 2008, CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases, Am J Clin Pathol, 129, 526, 10.1309/W01Y0B808EMEH12L Xiao, 2009, Proteomic analysis of cerebrospinal fluid from patients with idiopathic temporal lobe epilepsy, Brain Res, 1255, 180, 10.1016/j.brainres.2008.12.008 Sengupta, 2015, Cerebrospinal fluid biomarkers of Japanese encephalitis, F1000Research, 4, 334, 10.12688/f1000research.6801.1 Yang, 2013, Vitamin D-binding protein in cerebrospinal fluid is associated with multiple sclerosis progression, Mol Neurobiol, 47, 946, 10.1007/s12035-012-8387-1 Perga, 2015, Vitamin D binding protein isoforms and apolipoprotein E in cerebrospinal fluid as prognostic biomarkers of multiple sclerosis, PLoS One, 10, 10.1371/journal.pone.0129291 Lee, 2016, Discovery of serum protein biomarkers in drug-free patients with major depressive disorder, Prog Neuro-Psychopharmacol Biol Psychiatry, 69, 60, 10.1016/j.pnpbp.2016.04.009 Xu, 2012, Comparative proteomic analysis of plasma from major depressive patients: identification of proteins associated with lipid metabolism and immunoregulation, Int J Neuropsychopharmacol, 15, 1413, 10.1017/S1461145712000302